|
Significant Vendor (Details Textual) (USD $)
|
3 Months Ended | 3 Months Ended | 3 Months Ended | 12 Months Ended | 3 Months Ended | |||||
|---|---|---|---|---|---|---|---|---|---|---|
|
Sep. 30, 2014
|
Sep. 30, 2013
|
Jun. 30, 2014
|
Sep. 30, 2014
Settlement Agreement [Member]
|
Jun. 30, 2013
Settlement Agreement [Member]
|
Sep. 30, 2014
Amended Agreement [Member]
|
Jun. 30, 2013
Amended Agreement [Member]
|
Sep. 30, 2014
Fraunhofer [Member]
|
Sep. 30, 2013
Fraunhofer [Member]
|
Jun. 30, 2014
Fraunhofer [Member]
|
|
| Significant Vendor [Line Items] | ||||||||||
| Accounts Payable, Current | $ 516,000 | $ 297,000 | $ 1,200,000 | $ 555,000 | $ 205,000 | |||||
| Accrued Liabilities, Current | 702,000 | 98,000 | 1,700,000 | |||||||
| Research and Development Expense | 1,185,000 | 552,000 | 1,040,000 | 1,007,000 | 819,000 | (758,000) | ||||
| Royalty Expense | 200,000 | |||||||||
| Royalty Guarantees, Commitments, Amount | 4,000,000 | |||||||||
| Prepaid Expense | 1,000,000 | |||||||||
| General and Administrative Expense Settlement | 1,050,000 | 949,000 | 700,000 | |||||||
| Earnings From Reversal of Expenses | 1,900,000 | |||||||||
| Interest Expense, Total | 122,000 | |||||||||
| Accounts Receivable, Net, Current, Total | 0 | 205,000 | 1,007,000 | |||||||
| Revenue, Net, Total | $ 819,000 | $ 0 | $ 819,000 | |||||||
| X | ||||||||||
|
- Definition
Earnings From Reversal of Expenses. No definition available.
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of the cost of borrowed funds accounted for as interest expense. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Carrying amount as of the balance sheet date of expenditures made in advance of when the economic benefit of the cost will be realized, and which will be expensed in future periods with the passage of time or when a triggering event occurs. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The amount the entity has committed to make for future royalty guarantees. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|